关于规范肝癌命名的建议  

Suggestions on the nomenclature of liver cancer

作　　者：陈敏山[1] 徐立[1] 张耀军[1] 周仲国[1] 郭荣平[1] 元云飞[1] Chen Minshan;Xu Li;Zhang Yaojun;Zhou Zhongguo;Guo Rongping;Yuan Yunfei(Department of Liver Surgery,Sun Yat-sen University Cancer Center,Guangzhou 510082,China)

机构地区：[1]中山大学肿瘤防治中心肝脏外科,广州510082

出　　处：《中华医学杂志》2021年第26期2025-2028,共4页National Medical Journal of China

摘　　要：目前肝癌的命名很不规范,并与胆管癌命名混淆,作者在此提出自己的观点,希望能够为规范今后肝癌的命名与分类提供参考。我国“原发性肝癌诊疗规范(2019年版)”(以下简称“规范”)的前言部分指出:原发性肝癌主要包括肝细胞癌(HCC)、肝内胆管癌(ICC)和HCC-ICC混合型3种不同病理学类型,3者在发病机制、生物学行为、组织学形态、治疗方法以及预后等方面差异较大,其中HCC占85%-90%。本文就上述相关名称作详细分析并提出更正建议。Currently,the systematized nomenclature of medicine(SNOMED)of liver cancer is confusing,and it is mixed with the SNOMED of cholangiocarcinoma.We hereby presented our own points,hoping to provide a reference for standardizing the nomenclatures and classifications of liver cancer in future clinical studies.The preface of Chinese Guidelines of Primary Liver Cancer Diagnosis and Treatment(2019 Edition)indicated that primary liver cancer mainly includes three different pathological types,hepatocellular carcinoma(HCC),intrahepatic cholangiocarcinoma(ICC),and mixed-type carcinoma of both HCC and ICC.These three types of carcinoma show great differences in terms of pathogenesis,biological behavior,histological morphology,treatment methods,and prognosis,among which,HCC accounts for 85%to 90%.Therefore,this study is a detailed analysis of the above-mentioned related SNOMED and proposes suggestions for corrections.

关 键 词：肝肿瘤 肝细胞癌 胆管细胞癌 命名法 

分 类 号：R735.7[医药卫生—肿瘤]